Chester (Chip) Davis Jr., president and chief executive officer of the Healthcare Distribution Alliance, recently answered questions from Chain Drug Review about drug wholesaling in the aftermath of the pandemic and other industry issues. Read More
Conshohocken, Pa. (April 4, 2022) – Good Neighbor Pharmacy, AmerisourceBergen’s nationwide network of independent community pharmacies, today announced that it has exceeded 5 million COVID-19 vaccine doses allocated to independent pharmacies across the U.S. This allocation effort is a part of the Federal Retail Pharmacy Program for COVID-19 Vaccination, a collaboration between the Federal Government, […] Read More
Healthcare Ready, a national nonprofit organization working with public/private partners to strengthen the resiliency of communities before, during, and after disasters, today announced its 2021 “Heroes of the Supply Chain” honorees. Read More
When COVID-19 vaccines arrived in 2020, humanity had engineered a modern miracle. But there was a catch: We quickly learned that the Pfizer vaccine had to be shipped at ultra-cold temperatures, as low as -130°F. For most Americans, it was our first introduction to the logistical pains behind the “cold chain,” the chilly side of our […] Read More
Chief information officers have emerged as key players in their companies’ sustainability programs, leading efforts to unload power-hungry computer-processing applications to the cloud and roll out tech aimed at energy optimization and waste reduction. Their influence within these programs may grow in 2022, as the relationship between digitization and carbon-based emissions becomes more evident. A […] Read More
The Healthcare Distribution Alliance (HDA) today launched a campaign — “Health Delivered” — to communicate the healthcare distribution industry’s integral role and logistics expertise during the COVID-19 response, as well as distributors’ ongoing responsibility to fulfill the daily healthcare needs of all Americans. Read More
A report published by the Healthcare Distribution Alliance (HDA) Research Foundation and Deloitte Consulting LLP found that during the first 90 days of the COVID-19 pandemic, the biopharmaceutical finished goods industry quickly adapted and adjusted to deliver medicines safely and efficiently to patients, with only minimal disruptions. Read More
